Menthacarin® in the treatment of functional gastrointestinal disorders

You may not qualify if:

• Patient in whom abdominal symptoms are caused by an organic cause.
• Patient with constipation and/or changes in bowel movements alternating between normal bowel movements and constipation
• Evidence of structural abnormality of the gastrointestinal tract or diseases/conditions that affect bowel transit
• Patient is currently experiencing bloody diarrhoea
• Known hypersensitivity to peppermint, menthol, caraway, to umbelliferous plants or other ingredients of the investigational medicinal product
• Concomitant use of any other treatments for functional gastrointestinal disorders, including herbal preparations (other than the investigational medicinal product)
• Patient is suffering from reduced production of gastric acid (achlorhydria)
• Liver diseases
• Gallstones, inflammation of the bile duct (cholangitis) or other diseases of the gall
• Patient is immunocompromised (e.g. AIDS, lymphoma, long-term corticosteroid treatment).
• Patient with a malignant disease or undergoing chemotherapy or radiation therapy
• Patient with known or suspected history of alcohol or drug abuse according to the opinion of the investigator
• Female patient who is pregnant, breast-feeding or planning pregnancy during the course of this clinical trial
• Female patient of child-bearing potential not using or not willing to use consistently and correctly throughout the duration of this clinical trial one of the following contraceptive methods: established use of implants, injectables, or combined hormonal oral, intravaginal or transdermal contraceptives, placement of an intrauterine device (IUD) or intrauterine hormone-releasing system (IUS), sexual abstinence and vasectomised partner
• Patient exhibiting or indicating thoughts of suicide currently or in the past
• +3 more criteria